BriaCell Therapeutics Correlations
BCTXW Stock | USD 0.10 0.01 9.09% |
The current 90-days correlation between BriaCell Therapeutics and Reviva Pharmaceuticals Holdings is -0.09 (i.e., Good diversification). The correlation of BriaCell Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
BriaCell Therapeutics Correlation With Market
Significant diversification
The correlation between BriaCell Therapeutics Corp and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BriaCell Therapeutics Corp and DJI in the same portfolio, assuming nothing else is changed.
BriaCell |
Moving together with BriaCell Stock
0.71 | CDIOW | Cardio Diagnostics | PairCorr |
0.65 | ELVN | Enliven Therapeutics | PairCorr |
0.68 | SCLX | Scilex Holding | PairCorr |
0.73 | ASMB | Assembly Biosciences Downward Rally | PairCorr |
0.89 | CDIO | Cardio Diagnostics | PairCorr |
0.88 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.7 | MSFT | Microsoft | PairCorr |
0.61 | MRK | Merck Company | PairCorr |
Moving against BriaCell Stock
0.87 | GE | GE Aerospace | PairCorr |
0.85 | WM | Waste Management | PairCorr |
0.81 | PLX | Protalix Biotherapeutics | PairCorr |
0.78 | LUCD | Lucid Diagnostics | PairCorr |
0.39 | PG | Procter Gamble | PairCorr |
0.38 | ABUS | Arbutus Biopharma Corp | PairCorr |
0.31 | MLSS | Milestone Scientific Earnings Call Today | PairCorr |
0.88 | MMM | 3M Company | PairCorr |
0.79 | JNJ | Johnson Johnson | PairCorr |
0.79 | T | ATT Inc Aggressive Push | PairCorr |
0.77 | IBM | International Business | PairCorr |
0.74 | CVX | Chevron Corp | PairCorr |
0.71 | CSCO | Cisco Systems Aggressive Push | PairCorr |
0.6 | XOM | Exxon Mobil Corp Earnings Call This Week | PairCorr |
0.52 | INTC | Intel | PairCorr |
0.38 | DD | Dupont De Nemours | PairCorr |
0.34 | JPM | JPMorgan Chase Sell-off Trend | PairCorr |
Related Correlations Analysis
0.51 | 0.9 | -0.17 | 0.55 | BCTX | ||
0.51 | 0.4 | 0.36 | 0.57 | GOVXW | ||
0.9 | 0.4 | -0.21 | 0.46 | IMTXW | ||
-0.17 | 0.36 | -0.21 | 0.35 | ATNFW | ||
0.55 | 0.57 | 0.46 | 0.35 | RVPHW | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between BriaCell Stock performing well and BriaCell Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BriaCell Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
BCTX | 5.32 | (0.98) | 0.00 | (0.46) | 0.00 | 10.46 | 38.97 | |||
GOVXW | 12.89 | 0.72 | 0.04 | 0.35 | 13.32 | 41.67 | 96.13 | |||
IMTXW | 17.50 | (1.69) | 0.00 | (1.00) | 0.00 | 42.11 | 131.73 | |||
ATNFW | 8.01 | 1.02 | 0.10 | (0.64) | 8.67 | 13.00 | 133.33 | |||
RVPHW | 12.00 | (0.35) | 0.00 | 0.87 | 0.00 | 25.00 | 96.02 |
BriaCell Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BriaCell Therapeutics stock to make a market-neutral strategy. Peer analysis of BriaCell Therapeutics could also be used in its relative valuation, which is a method of valuing BriaCell Therapeutics by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
BriaCell Therapeutics Corporate Management
FACP MD | Founder Director | Profile | |
Miguel LopezLago | Chief Officer | Profile | |
Farrah Dean | Mang Devel | Profile | |
MD MPH | Chief Officer | Profile |